Literature DB >> 19439963

Unmet medical needs among patients with gastroesophageal reflux disease: a foundation for improving management in primary care.

Harley R Liker1, Philippe Ducrotté, Peter Malfertheiner.   

Abstract

Gastroesophageal reflux disease (GERD) is a common disease that has a significant impact on patients' health-related quality of life. While proton pump inhibitors have transformed GERD therapy, effective management of this disease is still a challenge. This review consolidates data from the recently published Burning Questions and Burning Desires surveys to provide a foundation for improved primary care management of GERD. First, the surveys confirm the significant troublesome impact of GERD on patients' health-related quality of life. Negative effects on sleeping and eating were identified as the leading causes for concern among such patients. Second, a lack of symptom control was identified among patients receiving physician-guided care for GERD, with many patients experiencing persistent symptoms. This was likely to be responsible for the third major finding of these surveys - the high rate of concomitant over-the-counter medication use among patients receiving prescription therapy. The surveys also uncovered a disconnect between patients and physicians in terms of GERD symptom severity, and perceptions of GERD and its treatment. Such findings outline the requirement for improved management of GERD, including the need to identify patients who may benefit from reassessment and more effective therapies. Patient-reported, questionnaire-based tools may aid physicians in this regard.

Entities:  

Mesh:

Year:  2009        PMID: 19439963     DOI: 10.1159/000210106

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  10 in total

1.  Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study.

Authors:  Brett MacFarlane; Andrew Matthews; Jenny Bergin
Journal:  Int J Clin Pharm       Date:  2015-05-14

2.  Many patients continue using proton pump inhibitors after negative results from tests for reflux disease.

Authors:  Andrew J Gawron; Jami Rothe; Angela J Fought; Anita Fareeduddin; Erin Toto; Lubomyr Boris; Peter J Kahrilas; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-22       Impact factor: 11.382

3.  Treatment of GORD: Three decades of progress and disappointments.

Authors:  Jean Paul Galmiche; Frank Zerbib; Stanislas Bruley des Varannes
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

4.  Non-pharmacological intervention for gastro-oesophageal reflux disease in primary care.

Authors:  Lesley B Dibley; Christine Norton; Roger Jones
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

5.  More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.

Authors:  Motoyasu Kusano; Hiroko Hosaka; Osamu Kawamura; Akiyo Kawada; Shiko Kuribayashi; Yasuyuki Shimoyama; Hidetoshi Yasuoka; Masafumi Mizuide; Taku Tomizawa; Toshihiko Sagawa; Ken Sato; Masanobu Yamada
Journal:  J Gastroenterol       Date:  2014-06-12       Impact factor: 7.527

6.  Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studies.

Authors:  J Ponce; V Garrigues; L Agréus; E Tabaglio; M Gschwantler; E Guallar; M Tafalla; J Nuevo; J Hatlebakk
Journal:  Int J Clin Pract       Date:  2012-07-16       Impact factor: 2.503

7.  What causes treatment failure - the patient, primary care, secondary care or inadequate interaction in the health services?

Authors:  Per G Farup; Ivar Blix; Sigurd Førre; Gjermund Johnsen; Ove Lange; Rune Johannessen; Hermod Petersen
Journal:  BMC Health Serv Res       Date:  2011-05-20       Impact factor: 2.655

Review 8.  Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.

Authors:  A Pali S Hungin; Michael Molloy-Bland; Carmelo Scarpignato
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

Review 9.  Improving Patient Adherence to Lifestyle Changes for the Management of Gastroesophageal Reflux.

Authors:  Livia Guadagnoli; Madison Simons; Josie McGarva; Tiffany H Taft; Miranda A L van Tilburg
Journal:  Patient Prefer Adherence       Date:  2022-04-05       Impact factor: 2.711

10.  High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

Authors:  James E Hilbert; Richard J Barohn; Paula R Clemens; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Amy L Parkhill; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.